![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 30925-07-6
2. L-cystine 2hcl
3. Cystine Dihydrochloride
4. L-cystine Hcl
5. Wfn1a47eig
6. L-cystine (dihydrochloride)
7. L-(-)-cystine Dihydrochloride
8. (2r)-2-amino-3-[[(2r)-2-amino-2-carboxyethyl]disulfanyl]propanoic Acid;dihydrochloride
9. (2r,2'r)-3,3'-disulfanediylbis(2-aminopropanoic Acid) Dihydrochloride
10. L-cystine, Dihydrochloride
11. Cystine, Dihydrochloride
12. Einecs 250-391-9
13. Mfcd00070399
14. Unii-wfn1a47eig
15. (h-cys-oh)2.2hcl
16. Schembl258646
17. Dtxsid101335748
18. Cs-w009919
19. Hy-w009203
20. L-cystine, Hydrochloride (1:2)
21. As-58844
22. L-cystine Dihydrochloride, >=98% (tlc)
23. A820655
24. S-(((r)-2-amino-2-carboxyethyl)thio)-d-cysteine Dihydrochloride
25. (2r)-2-amino-3-[[(2r)-2-amino-2-carboxyethyl]disulfanyl]propanoic Acid,hydrochloride
26. (2r)-2-amino-3-{[(2r)-2-amino-2-carboxyethyl]disulfanyl}propanoic Acid Dihydrochloride
27. L-cystine Dihydrochloride, From Non-animal Source, Bioreagent, Suitable For Cell Culture, >=98.0% Dry Basis
28. L-cystine Dihydrochloride, Non-animal Derived, Pharmagrade, Manufactured Under Appropriate Controls For Use As A Raw Material In Pharma Or Biopharmaceutical Production., Suitable For Cell Culture
Molecular Weight | 313.2 g/mol |
---|---|
Molecular Formula | C6H14Cl2N2O4S2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 7 |
Exact Mass | 311.9772047 g/mol |
Monoisotopic Mass | 311.9772047 g/mol |
Topological Polar Surface Area | 177 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 192 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |